Firms
RA Capital Management
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
Bain Capital
Cidara Therapeutics$240M · 2024-04-24Aiolos Bio$245M · 2023-10-25
Jnana Therapeutics$107M · 2022-11-15
Rivus Pharmaceuticals$132M · 2022-09-22Rivus Pharma$132M · 2022
ViaCyte$45M · 2021-06-09
Atea Pharmaceuticals$— · 2020-05-20
InflaRX$55M · 2017-10-13
Solid Biosciences$50M · 2017
Talawar$225M · Unknown date
ARCH Venture PartnersLifeMine$188M · 2026-08-06
Ollin$330M · 2026-06-24
Ollin Biosciences$330M · 2026
Parabilis Medicines$305M · Unknown date
Cormorant Asset Management
InflaRX$55M · 2017-10-13
Solid Biosciences$50M · 2017
Parabilis Medicines$305M · Unknown date
Founders FundAvalanche Energy$— · 2025-04-10
Synthego$100M · 2020-08-26
Avalanche$— · Unknown date
8090 Industries
Avalanche Energy$— · 2025-04-10
Avalanche$— · Unknown date
Atlas Venture
Aiolos Bio$245M · 2023-10-25
Triana Bio$110M · 2022-04-06
Canada Pension Plan Investment Board
Ollin$330M · 2026-06-24
Ollin Biosciences$330M · 2026
Commodore Capital
Ollin$330M · 2026-06-24
Ollin Biosciences$330M · 2026
Longitude Capital
Rivus Pharmaceuticals$132M · 2022-09-22Rivus Pharma$132M · 2022
Lowercarbon Capital
Avalanche Energy$— · 2025-04-10
Avalanche$— · Unknown date
Medicxi
Rivus Pharmaceuticals$132M · 2022-09-22Rivus Pharma$132M · 2022
Mubadala Ventures
Ollin$330M · 2026-06-24
Ollin Biosciences$330M · 2026
Overlay Capital
Avalanche Energy$— · 2025-04-10
Avalanche$— · Unknown date
Perceptive Advisors
Atea Pharmaceuticals$— · 2020-05-20
Solid Biosciences$50M · 2017
Pfizer Ventures
Jnana Therapeutics$107M · 2022-11-15Triana Bio$110M · 2022-04-06
T. Rowe Price
Ollin$330M · 2026-06-24
Ollin Biosciences$330M · 2026
Toyota Ventures
Avalanche Energy$— · 2025-04-10
Avalanche$— · Unknown date
Accel
Mitra RxDx$40M · 2018-07-12
Access Biotechnology
Talawar$225M · Unknown date
Adage Capital Management
ViaCyte$45M · 2021-06-09
AJU IB Investment
Atea Pharmaceuticals$— · 2020-05-20
Alphabet Inc.
Parabilis Medicines$305M · Unknown date
Asymmetry Ventures
ViaCyte$45M · 2021-06-09
Avon Ventures
Jnana Therapeutics$107M · 2022-11-15
B Capital
Synapticure$25M · 2024-11-19
Bezos Expeditions
LifeMine$188M · 2026-08-06
BVF Partners L.P.
Cidara Therapeutics$240M · 2024-04-24
Canaan Partners
Cidara Therapeutics$240M · 2024-04-24
Chugai Venture Fund
Stylus Medicine$45M · 2025-05-13
Deep Track Capital
Talawar$225M · Unknown date
Eli Lilly and Company
Stylus Medicine$45M · 2025-05-13
Farallon Capital Management
Talawar$225M · Unknown date
Forbion
Aiolos Bio$245M · 2023-10-25
Foresite Capital
Solid Biosciences$50M · 2017
Gates Frontier
LifeMine$188M · 2026-08-06
Intel Capital
Synthego$100M · 2020-08-26
Khosla Ventures
Stylus Medicine$45M · 2025-05-13
LightspeedTriana Bio$110M · 2022-04-06
Logos Capital
Triana Bio$110M · 2022-04-06
Menlo Ventures
Synthego$100M · 2020-08-26
MRL Ventures Fund
LifeMine$188M · 2026-08-06
Nexus NeuroTech Ventures
Synapticure$25M · 2024-11-19
Northpond Ventures
Mitra RxDx$40M · 2018-07-12
Optum Ventures
Synapticure$25M · 2024-11-19
Polaris Partners
Jnana Therapeutics$107M · 2022-11-15
Sands Capital
Mitra RxDx$40M · 2018-07-12
Scott Nolan
Synthego$100M · 2020-08-26
Sequoia
Mitra RxDx$40M · 2018-07-12
Sofinnova PartnersAiolos Bio$245M · 2023-10-25
Soleus Capital
Parabilis Medicines$305M · Unknown date
Surveyor Capital
Triana Bio$110M · 2022-04-06
The Invus Group, LLC
ViaCyte$45M · 2021-06-09
Versant Ventures
Jnana Therapeutics$107M · 2022-11-15
Wellington Management
Synthego$100M · 2020-08-26
Y Combinator
Synapticure$25M · 2024-11-19

